Abgenix, Inc. (ABGX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Abgenix, Inc. (ABGX)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Henry Niman who started this subject	11/5/2003 2:46:57 AM
From: bob zagorin	of 590

12:54PM Imclone Color (IMCL) : -- Update -- News that Imclone Systems' (IMCL 35.11 +0.62) Erbitux and Genentech's (DNA 81.49 +0.49) Avastin cancer drugs won't be reviewed by a U.S. FDA committee next month hitting the wires and causing volatility. According to our sources the news should be viewed as a positive because it shows the FDA's readiness to approve these drugs without additional request for data. Also ABGX (+0.18) with its ABX-EGF and OSIP (-0.49) with its Tarceva could move in sympathy. from briefing.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next